Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
RECURSION PHARMACEUTICALS, INC. (RXRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 8-K Quarterly results
08/11/2023 8-K/A Submission of Matters to a Vote of Security Holders  Interactive Data
08/08/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results",
"Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds",
"Decoding Biology To Radically Improve Lives End of Q2, 2023"
07/12/2023 8-K Quarterly results
06/13/2023 8-K Investor presentation
Docs: "of the Securities Litigation Reform Act of 1995. These"
06/09/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "REGISTRATION AGREEMENT",
"AUSTIN BEIJING BOSTON BRUSSELS HONG KONG LONDON LOS ANGELES NEW YORK PALO ALTO SAN DIEGO SAN FRANCISCO SEATTLE SHANGHAI WASHINGTON, DC WILMINGTON, DE"
05/25/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
05/16/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Recursion Appoints David Mauro, M.D., Ph.D.,"
05/08/2023 8-K Quarterly results
05/08/2023 8-K Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits  Interac...
Docs: "SALT LAKE CITY, TORONTO"
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
02/27/2023 8-K Investor presentation
Docs: "Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2022 Financial Results",
"End of Q4 2022"
01/25/2023 8-K Other Events  Interactive Data
Docs: "7 0.1 1 10 20201962 1970 1980 1990 2000 2010"
01/13/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
01/10/2023 8-K Investor presentation
Docs: "Investor presentation of Recursion Pharmaceuticals, Inc."
11/08/2022 8-K Quarterly results
10/25/2022 8-K Quarterly results
09/13/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "FORM 8-K",
"Recursion Initiates Two Additional Clinical Trials For a Total of Four in 2022"
08/09/2022 8-K Investor presentation, Quarterly results
Docs: "Recursion Provides Business Updates and Reports Second Quarter 2022 Financial Results",
"705 768 708 602 575 641 686 709 519 439 393 333 0 500 1,000 1,500 2,000 2,500 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021"
06/21/2022 8-K Quarterly results
06/16/2022 8-K Quarterly results
06/09/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
04/11/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "FORM 8-K",
"Recursion is Granted Fast Track Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis"
03/23/2022 8-K Investor presentation
Docs: "Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2021 Financial Results",
"End of Q4 2021"
03/18/2022 8-K Quarterly results
03/03/2022 8-K Quarterly results
01/10/2022 8-K Investor presentation
Docs: "Investor presentation of Recursion Pharmaceuticals, Inc."
12/07/2021 8-K Quarterly results
12/06/2021 8-K Quarterly results
11/10/2021 8-K Investor presentation
Docs: "Recursion Provides Business Updates and Reports Third Quarter 2021 Financials",
"0 20 40 60 80 100 120 140 160 180 200 0 5 10 15 20 25 30 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 4"
10/07/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Recursion is Granted FDA Fast Track Designation for REC-2282 for the Potential Treatment of NF2-Mutated Meningiomas"
09/09/2021 8-K Quarterly results
08/13/2021 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Recursion Reports Second Quarter 2021 Financials and Provides Business Updates"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy